Sean A. Mccarthy serves as Executive at CytomX Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Sean A. Mccarthy has executed 103 insider transactions totaling $8.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 3, 2017 involved selling 14,343 shares valued at $215.1K.
Sean A. Mccarthy currently holds 980,000 shares of CytomX Therapeutics, Inc. (CTMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sean A. Mccarthy has been a net seller of CTMX stock. They have purchased $0 and sold $8.1M worth of shares.
Sean A. Mccarthy's most recent insider trade was on Mar 3, 2017, when they sold 14,343 shares at $15.00 per share.
Get notified when new Form 4 filings are submitted
| $1.13 |
| Discretionary |
| Nov 30, 2016 | CTMX | $18.0K | Award | 1,979 | $9.10 | Discretionary |